Academic Journal

A novel method to generate T-cell receptor–deficient chimeric antigen receptor T cells

التفاصيل البيبلوغرافية
العنوان: A novel method to generate T-cell receptor–deficient chimeric antigen receptor T cells
المؤلفون: Takahiro Kamiya, Desmond Wong, Yi Tian Png, Dario Campana
المصدر: Blood Advances, Vol 2, Iss 5, Pp 517-528 (2018)
بيانات النشر: Elsevier, 2018.
سنة النشر: 2018
المجموعة: LCC:Specialties of internal medicine
مصطلحات موضوعية: Specialties of internal medicine, RC581-951
الوصف: Abstract: Practical methods are needed to increase the applicability and efficacy of chimeric antigen receptor (CAR) T-cell therapies. Using donor-derived CAR-T cells is attractive, but expression of endogenous T-cell receptors (TCRs) carries the risk for graft-versus-host-disease (GVHD). To remove surface TCRαβ, we combined an antibody-derived single-chain variable fragment specific for CD3ε with 21 different amino acid sequences predicted to retain it intracellularly. After transduction in T cells, several of these protein expression blockers (PEBLs) colocalized intracellularly with CD3ε, blocking surface CD3 and TCRαβ expression. In 25 experiments, median TCRαβ expression in T lymphocytes was reduced from 95.7% to 25.0%; CD3/TCRαβ cell depletion yielded virtually pure TCRαβ-negative T cells. Anti-CD3ε PEBLs abrogated TCRαβ-mediated signaling, without affecting immunophenotype or proliferation. In anti-CD3ε PEBL-T cells, expression of an anti-CD19-41BB-CD3ζ CAR induced cytokine secretion, long-term proliferation, and CD19+ leukemia cell killing, at rates meeting or exceeding those of CAR-T cells with normal CD3/TCRαβ expression. In immunodeficient mice, anti-CD3ε PEBL-T cells had markedly reduced GVHD potential; when transduced with anti-CD19 CAR, these T cells killed engrafted leukemic cells. PEBL blockade of surface CD3/TCRαβ expression is an effective tool to prepare allogeneic CAR-T cells. Combined PEBL and CAR expression can be achieved in a single-step procedure, is easily adaptable to current cell manufacturing protocols, and can be used to target other T-cell molecules to further enhance CAR-T-cell therapies.
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2473-9529
Relation: http://www.sciencedirect.com/science/article/pii/S2473952920310752; https://doaj.org/toc/2473-9529
DOI: 10.1182/bloodadvances.2017012823
URL الوصول: https://doaj.org/article/c2087e3a41dd420c97c6b90004e38cd0
رقم الانضمام: edsdoj.2087e3a41dd420c97c6b90004e38cd0
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:24739529
DOI:10.1182/bloodadvances.2017012823